搜索结果: 1-6 共查到“esophageal cancer”相关记录6条 . 查询时间(0.221 秒)
Trans-Thoracic versus Trans-Hiatal Esophagectomy Complications and Outcomes in Patients with Esophageal Cancer in Shohada-E-Tajrish Hospital, Tehran, Iran;2000-2008
Esophageal cancer Trans-hiatal esophagectomy Trans-thoracic esophagectomy
2015/9/21
Background: Esophageal cancer is a poor-prognosis cancer which is common in Iran. The main treatment for this cancer is surgery which may be performed with either trans-thoracic (TTE) or trans-hiatal ...
The relationship of serum CEA and CA 19-9 levels to liver metastasis and pancreatic invasion in esophageal cancer
Esophageal cancer metastasis tumor marker CEA CA 19-9
2010/1/11
Aim: Previous studies have examined levels of CEA and CA 19-9 in esophageal cancer patients, but have not determined a significant relationship between CEA and CA 19-9 levels and liver metastasis and ...
Clinical Experience with Smart Care for Respiratory Managementafter Esophageal Cancer Surgery
Smart Care Esophageal carcinoma Ventilator
2009/7/14
Smart Care ® (SC) is an automated weaning system which has been newly installed in the Evita XL Ventilator made by Dräger Medical (Lubeck, Germany). This study was performed to investigate th...
Survival in esophageal cancer patients with hematogenous distant organ metastases
Esophageal cancer metastasis survey
2009/7/6
Objective: Esophageal cancer is a rapidly progressive cancer. In the majority of patients local invasion or distant metastasis may be present at the time of diagnosis. The present study reviewed the r...
Bax/Bcl-2 expression levels of 2-methoxyestradiol-exposed esophageal cancer cells
Bax/Bcl-2 expression 2-methoxyestradiol-exposed esophageal cancer cells
2009/3/2
2-Methoxyestradiol (2ME), an endogenous metabolite of 17β-estradiol, has been reported to play an active role in the induction of apoptosis in both proliferating endothelial and cancer cells. Since ...
IMMUNOHISTOCHEMICAL EXPRESSION OF p53 AND BCL-2 PROTEINS IN ADVANCED ESOPHAGEAL CANCER PATIENTS
Esophageal cancer p53 Bcl-2 immunohistochemistry molecular markers
2010/2/3
The current challenges in the management of esophageal cancer are to obtain a better understanding of underlying molecular alterations to provide new treatment options. We studied the p53 and Bcl-2 pr...